Explore evidence

0.55 episodes_per_person_yearIn the 14 months after the first dose of vaccine, the incidence of first episodes of clinical malaria in the first 6000 children aged 5 to 17 months was 0.55 episodes per person-year in the control group.

Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287

46 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of approximately 46% in children aged 5–17 months.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

0.4 proportionThe kdr frequency varied from 0.4 to 0.97 in Anopheles gambiae populations from the Sudanian region of Burkina Faso from August to October 2006.

Burkina Fasopaludismeobserved August to October 2006published 2009Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 5 observations

1.6 odds_ratioThe haplotype GGC is associated with increased risk of HIV-1 infection with an odds ratio of 1.6 [1.1–2.3] and p-value < 0.05.

Burkina FasoVIH/sidapublished 2016PloS oneeurope_pmcdocument of 4 observations

0.29 odds_ratioIn Burkina Faso, the odds of malaria were lower 1 month post-SMC administration, with an odds ratio of 0.29, after controlling for seasonal factors, age, sex, net use and other variables.

Burkina Fasopaludismepublished 2022BMJ global healthPubMeddocument of 8 observations

Full susceptibility to organophosphates was observed in Vallée du Kou (VK).

Burkina Fasopaludismepublished 2013Geneeurope_pmcdocument of 6 observations

71.3 %The prevalence of Pfdhfr mutation N51I was 71.3% among 101 genotyped samples.

Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations

1.29 %In Sector 10, the morbidity rate for severe malaria among people over 5 years of age was 1.29% in 2022.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 110 observations

100 %All 135 tested Plasmodium falciparum isolates were susceptible to quinine in Bobo-Dioulasso, Burkina Faso, during July to November 1997.

Burkina Fasopaludismeobserved July to November 1997published 2001Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 4 observations

56.7 %The prevalence of HBV was 56.7% among HIV-1 positive patients in the study population in Burkina Faso.

Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations

12.8 %The prevalence of hepatitis B virus infection in Burkina Faso decreased from 12.80% between 1996 and 2001 to 11.11% between 2012 and 2017.

Burkina Fasohépatite Bobserved 1996–2001published 2018BMC public healtheurope_pmcdocument of 12 observationsDOI 10.1186/s12889-018-5432-7

0.6 proportionThe kdr frequency in the M form of Anopheles gambiae increased to 0.6 in Burkina Faso compared to the 2000 survey.

Burkina Fasopaludismeobserved 2000published 2009Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument of 5 observations

53 %The positive predictive value for fever was 53% among pregnant women with suspected clinical malaria.

Burkina Fasopaludismepublished 2013Malaria journaleurope_pmcdocument of 9 observations

20 %20% of infants experienced the first clinical malaria episode before 6 months of age in a birth cohort of 734 infants in Nanoro health district, rural Burkina Faso.

Burkina Fasopaludismepublished 2018Malaria journaleurope_pmcdocument of 3 observations

84.6 %Among pregnant women aged 18–25 years in Ouagadougou, Burkina Faso, the prevalence of anti-rubella IgG was 84.6%.

Burkina Fasorubellapublished 2012Asian Pacific journal of tropical medicineeurope_pmcdocument of 8 observations

8.69 %The overall seroprevalence rate of HCV among blood donors in Burkina Faso was 8.69%.

Burkina Fasohépatite Cpublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations

2.4 %All-cause mortality was higher in RTS,S/AS01-vaccinated versus control girls (2.4% vs 1.3%, all ages).

Burkina Fasopaludismepublished 2019Human vaccines & immunotherapeuticseurope_pmcdocument of 7 observations

96.4 %In 2016, Burkina Faso reported a monthly Ministry of Health seasonal malaria chemoprevention coverage rate of 96.4%.

Burkina Fasopaludismeobserved 2016HAL · Unilimdocument of 110 observations

26.9 %Mosquito density was 26.9% (19,656/73,101) in year 3 of the study.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

72 %Among 99 HBV strains from HBsAg positive candidate blood donors in Ouagadougou, HBV genotype E had a prevalence of 72%.

Burkina Fasohépatite Bpublished 2016Journal of medical virologyeurope_pmcdocument of 4 observations

37 %Gastro-intestinal infections accounted for 37.0% of non-malaria infections in febrile children under 5 years of age in rural Burkina Faso.

Burkina Fasogastro-intestinal infectionspublished 2018Infectious diseases of povertyeurope_pmcdocument of 11 observations

1.75 %Vertical transmission of HIV was 1.75% (2/114) among mothers under prophylaxis.

Burkina FasoVIH/sidapublished 2015Global health actioneurope_pmcdocument of 5 observations

1.9 %In Banfora, the sporozoite infection rate (SIR) was 1.9% in year 3.

Burkina Fasopaludismeobserved year 3HAL · Unilimdocument of 87 observations

121 EU/mLAn anti-circumsporozoite antibody titre of 121 EU/mL was estimated to prevent 50% of infections.

Burkina Fasopaludismepublished 2015The Lancet. Infectious diseaseseurope_pmcdocument of 5 observations

42.9 %In nonpregnant women, parasitemia prevalence was 42.9% in the iron supplementation group and 39.2% in the control group.

Burkina Fasopaludismepublished 2018The Journal of infectious diseaseseurope_pmcdocument of 7 observations